4//SEC Filing
Rice John McCune Jr. 4
Accession 0001127602-21-004635
CIK 0000794172other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 3:02 PM ET
Size
11.9 KB
Accession
0001127602-21-004635
Insider Transaction Report
Form 4
Rice John McCune Jr.
Director
Transactions
- Sale
Common Stock
2021-02-08$28.16/sh−16,480$464,008→ 24,437 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-02-08−17,205→ 0 totalExercise: $10.46Exp: 2030-01-30→ Common Stock (17,205 underlying) - Exercise/Conversion
Common Stock
2021-02-08$10.46/sh+17,205$179,964→ 40,917 total - Exercise/Conversion
Common Stock
2021-02-08$13.55/sh+10,000$135,500→ 23,712 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-02-08−10,000→ 0 totalExercise: $13.55Exp: 2027-08-08→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Prices range from $27.47 per share to $28.62 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- [F2]These options were awarded under the 2012 Stock Incentive Plan and vested 25% every 40 days from the August 8, 2017 grant date.
- [F3]These options were awarded under the 2012 Stock Incentive Plan and vested 25% every 90 days from the January 29, 2020 grant date.
Documents
Issuer
MERIDIAN BIOSCIENCE INC
CIK 0000794172
Entity typeother
Related Parties
1- filerCIK 0001714030
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 3:02 PM ET
- Size
- 11.9 KB